Morphology and Toxicity of Aβ-(1-42) Dimer Derived from Neuritic and Vascular Amyloid Deposits of Alzheimer's Disease

Abstract

In the course of analyzing the chemical composition of Alzheimer's disease neuritic and vascular amyloid, we have purified stable dimeric and trimeric components of A␤ peptides. These peptides (molecular mass 9.0 and 13.5 kDa) were separated by size exclusion chromatography in the presence of 80% formic acid or 5 M guanidine thiocyanate, pH 7.4. The average ratio of monomers, dimers, and trimers was 55:30:15, respectively. Similar structures were produced over time upon incubation of synthetic A␤-(1-42) at pH 7.4. The stability of these oligomeric forms was also demonstrated by Western blot and mass spectrometry. Atomic force microscopy and electron microscopy rotary shadowing revealed that the monomers polymerized into 8 -10-nm filaments, whereas the dimers generated prolate ellipsoids measuring 3-4 nm in diameter. Although evidence implicates ␤-amyloid peptide (A␤) in the pathogenesis of Alzheimer's disease (AD) 1 (reviewed in Ref. 1), little is known about the nature of the A␤ mediating the pathology. Toxicity initially was attributed to aggregated A␤ in amyloid plaques (1), the morphological hallmarks of AD brains. A␤-(1-42) is the major peptide constituent of amyloid plaques (2), and increased production of the 42-amino acid peptide correlates with an earlier onset of AD (1). However, recent studies show that small quantities of A␤-(1-42) also exists as soluble peptide in the plasma, cerebrospinal fluid, and cerebral cortex of AD and normal individuals and are also secreted by cells in tissue culture (3-13). Utilizing ultracentrifugation, graded membrane filtration, and ELISA, we have recently isolated and quantitated the oligomeric water-soluble A␤ present in the brains of AD and control individuals (13). The levels of insoluble A␤ in AD brains are at least 100 times higher than those found in control brains. The amounts of water-soluble A␤ in AD brains are approximately six times higher than those detected in control brains. Interestingly, we isolated an A␤ fraction, from the A␤ water-soluble oligomeric pool, with a molecular mass of Ͻ10 kDa containing monomeric and/or dimeric forms of A␤ peptide (13). In all probability these peptides represent the initial building blocks that may ultimately aggregate into insoluble A␤ filaments. In the course of analyzing the chemical composition of AD neuritic plaque and vascular amyloid, we have purified stable dimeric and trimeric components of A␤-(1-40/42) (2, 14 -15). In the present study we report the chemical and morphological characteristics of the dimeric A␤ as elucidated by atomic force microscopy and transmission electron microscopy techniques. In addition, the potential for toxicity of the AD brain-derived A␤-(1-40/42) dimer was assessed on glial-neuronal cell cultures. MATERIALS AND METHODSPurification of A␤-(1-42) from AD Brain-Brains were obtained from eight patients who died of AD (postmortem delay 3-6 h). After separation of the leptomeninges, the right hemispheres were frozen at Ϫ70°C. Examination of the left hemispheres revealed numerous neuritic plaq...

Clearance mechanisms of Alzheimer's amyloid-β peptide: implications for therapeutic design and diagnostic tests

“…31 The toxicity of these pre-fibrillar Ab assemblies has been investigated by a number of researchers. Soluble, non-fibrillar assemblies of Ab have been shown to be neurotoxic in cell lines and block long term potentiation (LTP) in organotypic mouse brain slices within a short time course.…”

Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior

“…[47,67]. Dimeric, trimeric and apparently tetrameric soluble oligomers have been described in cultured cells [47,67], and SDS-stable oligomers of varying sizes have also been detected by Western blotting in APP transgenic mouse brain and human brain [14,16,27,33,40,49]. Such natural (i.e., non-synthetic) Aβ oligomers can be resistant not only to SDS but also to chaotropic salts like guanidine hydrochloride and to the Aβ-degrading protease IDE (insulin-degrading enzyme), which can only efficiently digest monomeric Aβ [65].…”

Preparation and characterization of toxic Aβ aggregates for structural and functional studies in Alzheimer's disease research

“…SEC, in particular, offers several advantages: (i) a variety of column matrices with different separation capacities are readily available and can be used in isolation or in combination with other columns to obtain high-resolution separation and fractions containing Aβ aggregates of defined size distribution; (ii) generally, the columns are equipped with filters at the top that allow for the removal of fibrillar (or insoluble) material from the injected sample, thus ensuring that the Aβ fractions are free of fibrillar seeds; (iii) if SEC is coupled to a light-scattering detector, accurate determination of Aβ aggregates' size distribution becomes possible 20 ; (iv) in analytical mode, SEC is a valuable tool to monitor early events in amyloid formation and quantification of monomer and/or protofibril loss during the time course of fibril formation 21 ; and (v) by choosing proper running conditions (i.e., buffer pH and contents), fractions are obtained in solution conditions suitable for biological systems, free of harmful or undesired substances (e.g., organic solvents and so on). SEC has also been successfully used to isolate Aβ oligomers (such as dimers and trimers) and high-molecular-weight aggregates (including protofibrils and amorphous aggregates) from complex cell culture media 55 or from postmortem AD brain extracts 56 .…”